I

Instituto Rosenbusch SA
BCBA:ROSE

Watchlist Manager
Instituto Rosenbusch SA
BCBA:ROSE
Watchlist
Price: 232.5 ARS -0.21%
Market Cap: 9.9B ARS

Net Margin

14.8%
Current
Improving
by 10.4%
vs 3-y average of 4.4%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.8%
=
Net Income
911.1m
/
Revenue
6.1B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
14.8%
=
Net Income
ARS911.1m
/
Revenue
6.1B

Peer Comparison

Country Company Market Cap Net
Margin
AR
Instituto Rosenbusch SA
BCBA:ROSE
9.9B ARS
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
533.1B USD
Loading...
CH
Roche Holding AG
SIX:ROG
276.8B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.9B GBP
Loading...
CH
Novartis AG
SIX:NOVN
221.5B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
146B USD
Loading...
FR
Sanofi SA
PAR:SAN
96.9B EUR
Loading...

Market Distribution

Higher than 74% of companies in Argentina
Percentile
74th
Based on 129 companies
74th percentile
14.8%
Low
-11 625% — -2.9%
Typical Range
-2.9% — 12%
High
12% — 19 017.3%
Distribution Statistics
Argentina
Min -11 625%
30th Percentile -2.9%
Median 7.9%
70th Percentile 12%
Max 19 017.3%

Instituto Rosenbusch SA
Glance View

Market Cap
9.9B ARS
Industry
Pharmaceuticals

Instituto Rosenbusch SA engages in the manufacture and marketing of veterinary products. The company is headquartered in Buenos Aires, Buenos Aires. The company went IPO on 2008-02-21. The firm's products are structured in two lines: Pharmaceutical, including antibiotics, antimastitics products, antimycotics, antiparasites, vitamins, minerals and other chemotherapies, and Biological, comprising vaccines for cattle, equines, porks and sheeps and dogs. The company is also involved in the slaughtering and provision of meat products. As of December 31, 2011, the Company owned such subsidiaries as Laboratorios Rosenbusch SA, Laboratorios Bolivar SA and Rosenbusch Paraguay SA.

ROSE Intrinsic Value
Not Available
I
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
14.8%
=
Net Income
911.1m
/
Revenue
6.1B
What is Instituto Rosenbusch SA's current Net Margin?

The current Net Margin for Instituto Rosenbusch SA is 14.8%, which is above its 3-year median of 4.4%.

How has Net Margin changed over time?

Over the last 3 years, Instituto Rosenbusch SA’s Net Margin has increased from -3.7% to 14.8%. During this period, it reached a low of -5.3% on Sep 30, 2021 and a high of 14.8% on May 1, 2024.

Back to Top